A detailed history of Wolff Wiese Magana LLC transactions in Amgen Inc stock. As of the latest transaction made, Wolff Wiese Magana LLC holds 8,672 shares of AMGN stock, worth $2.71 Million. This represents 2.17% of its overall portfolio holdings.

Number of Shares
8,672
Previous 9,918 12.56%
Holding current value
$2.71 Million
Previous $2.86 Million 13.69%
% of portfolio
2.17%
Previous 2.77%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024

SELL
$268.87 - $324.56 $335,012 - $404,401
-1,246 Reduced 12.56%
8,672 $2.47 Million
Q4 2023

Jan 16, 2024

SELL
$255.7 - $288.46 $194,076 - $218,941
-759 Reduced 7.11%
9,918 $2.86 Million
Q3 2023

Oct 30, 2023

BUY
$218.65 - $271.46 $13,993 - $17,373
64 Added 0.6%
10,677 $2.87 Million
Q2 2023

Aug 01, 2023

BUY
$214.27 - $253.37 $8,356 - $9,881
39 Added 0.37%
10,613 $2.36 Million
Q1 2023

Apr 18, 2023

BUY
$225.79 - $275.2 $97,541 - $118,886
432 Added 4.26%
10,574 $2.56 Million
Q4 2022

Feb 08, 2023

BUY
$229.03 - $291.01 $17,177 - $21,825
75 Added 0.75%
10,142 $2.66 Million
Q3 2022

Oct 26, 2022

SELL
$224.46 - $253.15 $208,298 - $234,923
-928 Reduced 8.44%
10,067 $2.27 Million
Q2 2022

Jul 15, 2022

SELL
$230.71 - $256.74 $10,843 - $12,066
-47 Reduced 0.43%
10,995 $2.68 Million
Q1 2022

May 09, 2022

SELL
$219.27 - $242.57 $259,615 - $287,202
-1,184 Reduced 9.68%
11,042 $2.67 Million
Q4 2021

Jan 18, 2022

BUY
$198.88 - $227.6 $189,532 - $216,902
953 Added 8.45%
12,226 $2.75 Million
Q3 2021

Oct 15, 2021

BUY
$212.27 - $248.7 $319,466 - $374,293
1,505 Added 15.41%
11,273 $2.4 Million
Q2 2021

Jul 15, 2021

BUY
$233.58 - $259.14 $13,080 - $14,511
56 Added 0.58%
9,768 $2.38 Million
Q1 2021

Apr 15, 2021

BUY
$221.91 - $258.6 $148,679 - $173,262
670 Added 7.41%
9,712 $2.42 Million
Q4 2020

Jan 27, 2021

BUY
$216.38 - $257.67 $1.96 Million - $2.33 Million
9,042 New
9,042 $2.08 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $167B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Wolff Wiese Magana LLC Portfolio

Follow Wolff Wiese Magana LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolff Wiese Magana LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolff Wiese Magana LLC with notifications on news.